A CD36-dependent signaling cascade is necessary for macrophage foam cell formation

被引:451
作者
Rahaman, S. Ohidar
Lennon, David J.
Febbraio, Maria
Podrez, Evgeny A.
Hazen, Stanley L.
Silverstein, Roy L.
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10021 USA
关键词
D O I
10.1016/j.cmet.2006.06.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulation of macrophage foam cells in atherosclerotic blood vessel intima is a critical component of atherogenesis mediated by scavenger receptor-dependent internalization of oxidized LDL. We demonstrated by coimmunoprecipitation and pull-down assays that the macrophage scavenger receptor CD36 associates with a signaling complex containing Lyn and MEKK2. The MAP kinases JNK1 and JNK2 were specifically phosphorylated in macrophages exposed to oxLDL. Using cells isolated from SRA, TLR2, or CD36 null mice, and phospholipid ligands specific for either SRA or CD36, we showed that JNK activation was mediated by CD36. Both foam cell formation and activation of JNK2 in hyperlipidemic mice were diminished in the absence of CD36. Furthermore, inhibition of Src or JNK blocked oxLDL uptake and inhibited foam cell formation in vitro and in vivo. These findings show that a specific CD36-dependent signaling pathway initiated by oxLDL is necessary for foam cell formation and identify potential targets for antiatherosclerosis therapy.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 47 条
[1]  
Bamberger ME, 2003, J NEUROSCI, V23, P2665
[2]   SRC-RELATED PROTEIN-TYROSINE KINASES ARE PHYSICALLY ASSOCIATED WITH THE SURFACE-ANTIGEN CD36 IN HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELLS [J].
BULL, HA ;
BRICKELL, PM ;
DOWD, PM .
FEBS LETTERS, 1994, 351 (01) :41-44
[3]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[4]   The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia [J].
Cho, S ;
Park, EM ;
Febbraio, M ;
Anrather, J ;
Park, L ;
Racchumi, G ;
Silverstein, RL ;
Iadecola, C .
JOURNAL OF NEUROSCIENCE, 2005, 25 (10) :2504-2512
[5]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[6]   CD36 mediates the innate host response to β-amyloid [J].
El Khoury, JB ;
Moore, KJ ;
Means, TK ;
Leung, J ;
Terada, K ;
Toft, M ;
Freeman, MW ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1657-1666
[7]  
Fadok VA, 1998, J IMMUNOL, V161, P6250
[8]   A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism [J].
Febbraio, M ;
Abumrad, NA ;
Hajjar, DP ;
Sharma, K ;
Cheng, WL ;
Pearce, SFA ;
Silverstein, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19055-19062
[9]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[10]  
Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006